| Dr William Frederick Feldner, DO | |
|
1011 Bowles Ave, St Francis Bldg., Suite 450, Fenton, MO 63026-2395 | |
| (314) 467-1500 | |
| (314) 467-1515 |
| Full Name | Dr William Frederick Feldner |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 1011 Bowles Ave, Fenton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922085539 | NPI | - | NPPES |
| 205157803 | Medicaid | MO | |
| 205157811 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | R1J82 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health At Home Home Health-st Louis | Saint louis, MO | Home health agency |
| Ssm St Clare Health Center | Fenton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Multispecialty Group Inc | 1658365572 | 151 |
News Archive
A multidisciplinary team led by Scott Rodeo, MD, and Christopher Mendias, PhD, at Hospital for Special Surgery has been awarded the Orthopaedic Research and Education Foundation Clinical Research Grant in Cellular Therapy in honor of James Urbaniak, MD in Collaboration with National Stem Cell Foundation.
High baseline serum levels of interleukin-23 can help to identify hepatitis B e antigen-positive chronic hepatitis B patients who are likely to respond to pegylated interferon treatment, a Chinese study indicates.
New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Toxic environmental contaminants are increasingly known to cause a number of severe health problems, in particular on fetuses, including heart failure, low cognitive ability, delayed development, and neurobehavioral disorders.
› Verified 9 days ago
| Entity Name | American Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559532 PECOS PAC ID: 1658365572 Enrollment ID: O20040413001412 |
News Archive
A multidisciplinary team led by Scott Rodeo, MD, and Christopher Mendias, PhD, at Hospital for Special Surgery has been awarded the Orthopaedic Research and Education Foundation Clinical Research Grant in Cellular Therapy in honor of James Urbaniak, MD in Collaboration with National Stem Cell Foundation.
High baseline serum levels of interleukin-23 can help to identify hepatitis B e antigen-positive chronic hepatitis B patients who are likely to respond to pegylated interferon treatment, a Chinese study indicates.
New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Toxic environmental contaminants are increasingly known to cause a number of severe health problems, in particular on fetuses, including heart failure, low cognitive ability, delayed development, and neurobehavioral disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Frederick Feldner, DO Po Box 23340, Saint Louis, MO 63156-3340 Ph: (314) 467-1500 | Dr William Frederick Feldner, DO 1011 Bowles Ave, St Francis Bldg., Suite 450, Fenton, MO 63026-2395 Ph: (314) 467-1500 |
News Archive
A multidisciplinary team led by Scott Rodeo, MD, and Christopher Mendias, PhD, at Hospital for Special Surgery has been awarded the Orthopaedic Research and Education Foundation Clinical Research Grant in Cellular Therapy in honor of James Urbaniak, MD in Collaboration with National Stem Cell Foundation.
High baseline serum levels of interleukin-23 can help to identify hepatitis B e antigen-positive chronic hepatitis B patients who are likely to respond to pegylated interferon treatment, a Chinese study indicates.
New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Toxic environmental contaminants are increasingly known to cause a number of severe health problems, in particular on fetuses, including heart failure, low cognitive ability, delayed development, and neurobehavioral disorders.
› Verified 9 days ago
Susan J. Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 Smizer Mill Rd Ste 1100, Fenton, MO 63026 Phone: 636-496-5023 | |
Sarah Ludlow, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 Smizer Mill Rd Ste 1100, Fenton, MO 63026 Phone: 636-496-5022 | |
Dr. John Martin Crowe Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1670 Fenpark Dr, Fenton, MO 63026 Phone: 636-492-6376 Fax: 636-326-6557 | |
Dr. Melissa Ann Muench, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd Ste 210, Fenton, MO 63026 Phone: 636-660-9850 Fax: 636-660-9851 | |
Dr. Justin E. Hugo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd, Suite 210, Fenton, MO 63026 Phone: 314-543-5230 Fax: 314-543-5280 | |
Mr. Christopher Paul Friesen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 320 Gravois Rd, Suite B, Fenton, MO 63026 Phone: 636-305-1899 Fax: 636-305-1898 | |
Brenda Lynn Buckley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1747 Smizer Station Rd, Suite 5, Fenton, MO 63026 Phone: 636-529-7000 Fax: 636-529-7003 |